Clinical Trial Update: Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial of capecitabine with weekly docetaxel followed by capecitabine maintenance for metastatic breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)
• Xeloda (capecitabine)

Snippet

Sponsor: Oncology Specialties, Alabama | Conditions: Metastatic Breast Cancer | Phase 2 | Status: TERMINATED